Indications
Raxone is indicated for the treatment of visual impairment in adolescent and adult patients with Leber’s Hereditary Optic Neuropathy (LHON).
Composition
- Active substance
- idebenone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Raxone
- Active substance
- idebenone
- ATC code
- N06BX13
- Group
- Nervous system
- Therapeutic area
- Optic Atrophy, Hereditary, Leber
- Marketing authorisation holder
- Chiesi Farmaceutici S.p.A
- Status
- Authorised
- EU authorisation
- 8 Sept 2015